David Patience
Chief Financial Officer · TriSalus Life Sciences, Inc.
- 2025
- Jul 6, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Patience files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael P. Stansky - $3.01M in TLSI purchases and sales in the last 12 months
- Mary T. Szela - $307K in TLSI purchases and sales in the last 12 months
- Mats Wahlstrom - $152K in TLSI purchases and sales in the last 12 months
- William Valle - $125K in TLSI purchases and sales in the last 12 months
- Gary B. Gordon - $65K in TLSI purchases and sales in the last 12 months
- Richard Marshak - $17K in TLSI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Patience?
David Patience is a corporate insider, tracked as Chief Financial Officer of TriSalus Life Sciences, Inc. (TLSI). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David Patience last file a Form 4?
The most recent primary Form 4 on record is dated 6 July 2026, one of 6 filings going back to 2025.
Has David Patience been buying or selling stock?
Recorded transactions: 2 open-market purchases ($32K) and 0 open-market sales across all tracked filings.
